Evidence map›Paper›PMID 34089422›Full record

Trial reportBreast cancer research and treatment2021

A randomized trial of exercise and diet on body composition in survivors of breast cancer with overweight or obesity.

Justin C Brown, David B Sarwer, Andrea B Troxel, Kathleen Sturgeon, Angela M DeMichele, Crystal S Denlinger, Kathryn H Schmitz

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Breast cancer research and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 12 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 12 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Observational
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Justin C BrownPennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA, 70808, USA.ORCID http://orcid.org/0000-0001-7540-4913
David B SarwerTemple University College of Public Health, 1101 W. Montgomery Ave, Philadelphia, PA, 1912, USA.
Andrea B TroxelNew York University Grossman School of Medicine, 180 Madison Ave, New York, NY, 10016, USA.
Kathleen SturgeonPenn State College of Medicine, 400 University Drive, Hershey, PA, 17033, USA.
Angela M DeMichelePerelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA, 19104, USA.
Crystal S DenlingerFox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, 19111, USA.
Kathryn H SchmitzPenn State College of Medicine, 400 University Drive, Hershey, PA, 17033, USA. kzs95@psu.edu.
Pennsylvania State University · USFox Chase Cancer Center · USNew York University · USPennington Biomedical Research Center · USTemple University · USUniversity of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI ROBERT A KESTERSON · 2005 to 2026
$26.5M
The Women In Steady Exercise Research (WISER) SurwVor TrialU54CA155850 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCHMITZ, KATHRYN H. · 2011 to 2015
$9.1M
Penn State Institutional Career Development CoreKL2TR002015 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI VAN SCOY, LAUREN JODI · 2016 to 2025
$7.8M
Transdisciplinary Research in Energetics and Cancer (TREC) Training GrantR25CA203650 · NCI · YALE UNIVERSITY · PI IRWIN, MELINDA L · 2016 to 2025
$2.9M
Psychopathology, Disordered Eating, and Impulsivity as Predictors of Outcomes of Bariatric SurgeryR01DK108628 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI SARWER, DAVID B · 2015 to 2019
$2.1M
Inflammation, Physical Activity, and Colon Cancer Recurrence and SurvivalR00CA218603 · NCI · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BROWN, JUSTIN C · 2019 to 2021
$747k
NCATS NIH HHS KL2 TR002015NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR001878NCATS NIH HHS UL1 TR002014NCI NIH HHS P30 CA006927NCI NIH HHS P30-CA006927NCI NIH HHS P30 CA016520NCI NIH HHS P30-CA016520NCI NIH HHS R00 CA218603NCI NIH HHS R00-CA218603NCI NIH HHS R25 CA203650NCI NIH HHS U54 CA155850NCI NIH HHS U54-CA155850NCI NIH HHS UL1-TR001878NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK108628NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

purposeObesity increases the risk of cancer recurrence and death in survivors of breast cancer. This study tested the hypothesis that exercise alone, diet alone, and the combination of exercise plus diet reduce body weight and improve body composition in survivors of breast cancer.

methodsIn this 2 × 2 factorial trial, 351 survivors of breast cancer with overweight or obesity were randomized to one of four treatment groups for 52 weeks: control, exercise alone, diet alone, or exercise plus diet. Endpoints included body weight and body composition measured by dual-energy x-ray absorptiometry.

resultsAfter 52 weeks, compared with control, diet alone [- 5.39 kg (95% CI - 7.24, - 3.55);- 6.0% (95% CI - 8.0, - 3.9)] and exercise plus diet [- 6.68 kg (95% CI - 8.46, - 4.90);- 7.4% (95% CI - 9.4, - 5.4)] reduced body weight; exercise alone did not change body weight. Compared with control, diet alone [- 3.59 kg (95% CI - 5.00, - 2.17)] and exercise plus diet [- 4.28 kg (95% CI - 5.71, - 2.84)] reduced fat mass; exercise alone did not change fat mass. Compared with control, diet alone [- 0.82 kg (95% CI - 1.50, - 0.15)] and exercise plus diet [- 1.24 kg (95% CI - 1.92, - 0.56)] reduced lean mass; exercise alone did not change lean mass. Compared with control, exercise alone, diet alone, and exercise plus diet did not change bone mineral density.

conclusionIn survivors of breast cancer with overweight or obesity, diet alone or diet plus exercise produced clinically meaningful weight loss at week 52. The majority of weight loss was fat mass.

Indexed as

Breast NeoplasmsBody CompositionBody Mass IndexDietFemaleHumansNeoplasm Recurrence, LocalObesityOverweightSurvivorsAdipose tissueBone densityDiet therapyExerciseMuscle

Identifiers

PMID34089422
PMCPMC8316406
OpenAlexW3164717364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.